Page 561 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 561

CHAPTER 30  Antidepressant Agents     547


                    insomnia or hypersomnia. Some patients gain weight while taking   hypotension in some patients. Nefazodone has been associated
                    SSRIs,  particularly  paroxetine.  Sudden  discontinuation  of  short   with hepatotoxicity, including rare fatalities and cases of fulminant
                    half-life SSRIs such as paroxetine and sertraline is associated with   hepatic failure requiring transplantation. The rate of serious hepa-
                    a discontinuation syndrome in some patients characterized by dizzi-  totoxicity with nefazodone has been estimated at 1 in 250,000 to
                    ness, paresthesias, and other symptoms beginning 1 or 2 days after   1 in 300,000 patient-years of nefazodone treatment.
                    stopping the drug and persisting for 1 week or longer.  As with the SSRIs, the most common adverse effects of vortiox-
                       Most antidepressants are category C agents by the FDA terato-  etine are serotonergic and include dose-dependent gastrointestinal
                    gen classification system. There is an association of paroxetine   effects, particularly nausea, as well as sexual dysfunction. Higher
                    with cardiac septal defects in first trimester exposures.  Thus,   doses of vortioxetine tend to increase the rate of GI and sexual side
                    paroxetine is a category D agent. Other possible associations of   effects. The teratogenic risks of vortioxetine are not known but like
                    SSRIs with post-birth complications, including pulmonary hyper-  most other antidepressants, it is considered a category C agent.
                    tension, have not been clearly established.
                                                                         D. Tetracyclics and Unicyclics
                    B. Serotonin-Norepinephrine Reuptake Inhibitors and   Amoxapine is sometimes associated with a parkinsonian syndrome
                    Tricyclic Antidepressants                            due to its D -blocking action. Mirtazapine has significant seda-
                                                                                   2
                    SNRIs have many of the serotonergic adverse effects associated   tive effect. Maprotiline has a moderately high affinity for NET
                    with SSRIs. In addition, SNRIs may also have noradrenergic   and may cause  TCA-like adverse effects and, rarely, seizures.
                    effects, including increased blood pressure and heart rate, and   Bupropion is occasionally associated with agitation, insomnia,
                    CNS  activation,  such as insomnia,  anxiety, and agitation. The   and anorexia. Vilazodone may have somewhat higher rates of gas-
                    hemodynamic effects of SNRIs tend not to be problematic in   trointestinal upset, including diarrhea and nausea, than the SSRIs.
                    most patients. A dose-related increase in blood pressure has been
                    seen more commonly with the immediate-release form of venla-  E. Monoamine Oxidase Inhibitors
                    faxine than with other SNRIs. Likewise, there are more reports   The most common adverse effects of the MAOIs leading to
                    of cardiac toxicity with venlafaxine overdose than with either the   discontinuation of these drugs are orthostatic hypotension and
                    other SNRIs or SSRIs. Duloxetine is rarely associated with hepatic   weight gain. In addition, the irreversible nonselective MAOIs
                    toxicity in patients with a history of liver damage. All the SNRIs   are associated with the highest rates of sexual effects of all the
                    have been associated with a discontinuation syndrome resembling   antidepressants. Anorgasmia is fairly common with therapeutic
                    that seen with SSRI discontinuation.                 doses of some MAOIs. The amphetamine-like properties of some
                       The primary adverse effects of TCAs have been described in   MAOIs contributes to activation, insomnia, and restlessness in
                    the previous text. Anticholinergic effects are perhaps the most   some patients. Phenelzine tends to be more sedating than either
                    common. These effects include dry mouth, constipation, urinary   selegiline or tranylcypromine. Confusion is also sometimes associ-
                    retention, blurred vision, and confusion. They are more common   ated with higher doses of MAOIs. Because they block metabolism
                    with tertiary amine TCAs such as amitriptyline and imipramine   of tyramine and similar ingested amines, MAOIs may cause dan-
                    than with the secondary amine TCAs desipramine and nortrip-  gerous interactions with certain foods and with serotonergic drugs
                    tyline. The potent α-blocking property of TCAs often results in   (see Interactions). Finally, MAOIs have been associated with a
                    orthostatic hypotension. H  antagonism by the TCAs is associated   sudden discontinuation syndrome manifested in a delirium-like
                                        1
                    with weight gain and sedation. The TCAs are class 1A antiarrhyth-  presentation with psychosis, excitement, and confusion.
                    mic agents (see Chapter 14) and are arrhythmogenic at higher
                    doses. Sexual effects are common, particularly with highly seroto-
                    nergic TCAs such as clomipramine. The TCAs have a prominent   OVERDOSE
                    discontinuation syndrome characterized by cholinergic rebound
                    and flulike symptoms.                                Suicide attempts are a common and unfortunate consequence
                                                                         of major depression. The lifetime risk of completing suicide in
                    C. 5-HT Receptor Modulators                          patients previously hospitalized with MDD may be as high as
                    The most common adverse effects associated with the 5-HT    15%.  Overdose  is  the  most  common  method  used  in  suicide
                                                                     2
                    antagonists are sedation and gastrointestinal disturbances. Seda-  attempts, and antidepressants, especially the TCAs, are frequently
                    tive effects, particularly with trazodone, can be quite pronounced.   involved. Overdose can induce lethal arrhythmias, including ven-
                    Thus, it is not surprising that the treatment of insomnia is cur-  tricular tachycardia and fibrillation. In addition, blood pressure
                    rently the primary application of trazodone. The gastrointestinal   changes and anticholinergic effects including altered mental status
                    effects appear to be dose-related and are less pronounced than   and seizures are sometimes seen in TCA overdoses. A 1500 mg
                    those seen with SNRIs or SSRIs. Sexual effects are uncommon   dose of imipramine or amitriptyline (less than 7 days’ supply at
                    with nefazodone or trazodone treatment as a result of the relatively   antidepressant doses) is enough to be lethal in many patients.
                    selective serotonergic effects of these drugs on the 5-HT  receptor   Toddlers taking 100 mg will likely show evidence of toxicity.
                                                              2
                    rather than on SERT. However, trazodone has rarely been associ-  Treatment typically involves cardiac monitoring, airway support,
                    ated with inducing priapism. Both nefazodone and trazodone are   and gastric lavage. Sodium bicarbonate is often administered to
                    α-blocking agents and may result in a dose-related orthostatic   displace the TCA from cardiac sodium channels.
   556   557   558   559   560   561   562   563   564   565   566